STOCK TITAN

Factorial Energy officer sells 30,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Factorial Energy Inc. (FAC) Principal Accounting Officer Jeffrey T. Scuteri Jr. was granted 15,000 RSUs on November 12, 2026; they vested in full and settled into 15,000 Series A common shares on November 13. That day, he exercised options for 20,495, 7,011 and 2,494 shares, each at $0.89 per share, and separately sold 30,000 shares at a weighted average $3.93 per share. On November 16, he sold 6,647 shares at a weighted average $3.77 per share to cover tax withholding. The issuer-required sell-to-cover sale was not discretionary; no Rule 10b5-1 plan is reported.

Insider Scuteri Jeffrey T. Jr.
Role Principal Accounting Officer
Sold 36,647 shs ($143K)
Approx. gross sale proceeds $143K
Share of Position Sold 81.4%
Type Security Shares Price Value
Sale Series A Common Stock F3, F4 6,647 $3.77 $25K
Exercise Restricted Stock Units F5, F6 15,000 $0.00 $0.00
Exercise Stock Option (Right to Buy) F7, F8 20,495 $0.00 $0.00
Exercise Stock Option (Right to Buy) F7, F9 7,011 $0.00 $0.00
Exercise Stock Option (Right to Buy) F7, F10 2,494 $0.00 $0.00
Exercise Series A Common Stock F1 15,000 $0.00 $0.00
Exercise Series A Common Stock 20,495 $0.89 $18K
Exercise Series A Common Stock 7,011 $0.89 $6K
Exercise Series A Common Stock 2,494 $0.89 $2K
Sale Series A Common Stock F2 30,000 $3.93 $118K
Grant/Award Restricted Stock Units F5, F6 15,000 $0.00 $0.00
Holdings After Transaction: Restricted Stock Units — 0 units (Direct); Stock Option (Right to Buy) — 82,205 options (Direct); Series A Common Stock — 8,353 shares (Direct)
Holdings Before and After: Restricted Stock Units, 0 to 0 units (Direct); Stock Option (Right to Buy), 112,205 to 82,205 options (Direct); Series A Common Stock, 0 to 8,353 shares (Direct)
Footnotes (10)
  1. F1. Represents shares of Series A Common Stock issued on settlement of RSUs that vested on November 13, 2026.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. Represents shares sold to cover tax withholding obligations arising from the vesting and settlement of RSUs. The Issuer requires these "sell-to-cover" sales; they are not discretionary trades by the Reporting Person.
  4. F4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.71 to $3.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series A Common Stock.
  6. F6. The RSUs were granted under the Issuer's 2026 Equity Incentive Plan in lieu of a cash payment of the Reporting Person's 2025 annual bonus and vested in full on November 13, 2026.
  7. F7. Previously reported as $0.88 due to rounding.
  8. F8. The shares underlying this option are fully vested and exercisable.
  9. F9. 25% of the shares underlying this option vested on May 8, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
  10. F10. 25% of the shares underlying this option vested on March 25, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
RSUs granted 15,000 RSUs Granted November 12, 2026, in lieu of cash payment for the 2025 annual bonus.
Shares issued on RSU settlement 15,000 Series A common shares RSUs vested and settled November 13, 2026.
Option exercise shares 20,495 shares Exercised November 13, 2026, at $0.89 per share; expiration date March 12, 2035.
Option exercise shares 7,011 shares Exercised November 13, 2026, at $0.89 per share; expiration date June 5, 2034.
Option exercise shares 2,494 shares Exercised November 13, 2026, at $0.89 per share; expiration date May 9, 2034.
Shares sold 30,000 shares at a weighted average $3.93 per share Sold November 13, 2026; transaction prices ranged from $3.90 to $3.98 per share.
Shares sold to cover tax withholding 6,647 shares at a weighted average $3.77 per share Sold November 16, 2026; transaction prices ranged from $3.71 to $3.77 per share.
restricted stock unit financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
sell-to-cover financial
"The Issuer requires these "sell-to-cover" sales"
Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.
weighted average price financial
"The price reported is a weighted average price"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
contingent right financial
"represents a contingent right to receive one share"
fully vested and exercisable technical
"shares underlying this option are fully vested and exercisable"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FAC shares did Jeffrey T. Scuteri Jr. sell, and at what prices?

He sold 30,000 Series A shares on November 13, 2026, at a weighted average $3.93 per share, with transaction prices from $3.90 to $3.98. On November 16, he sold 6,647 shares at a weighted average $3.77, with prices from $3.71 to $3.77, to cover tax withholding. The issuer required those sell-to-cover transactions; they were not discretionary. No Rule 10b5-1 plan is reported.

How many FAC options did Jeffrey T. Scuteri Jr. exercise?

On November 13, 2026, he exercised options covering 20,495, 7,011 and 2,494 Series A shares, each at an exercise price of $0.89 per share. Their respective expiration dates were March 12, 2035, June 5, 2034, and May 9, 2034.

Why did FAC grant Jeffrey T. Scuteri Jr. 15,000 RSUs?

The 15,000 RSUs were granted under the 2026 Equity Incentive Plan in lieu of cash payment for his 2025 annual bonus. Each RSU represents a contingent right to receive one Series A common share; the units vested in full on November 13, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Scuteri Jeffrey T. Jr.

(Last)(First)(Middle)
805 MIDDLESEX TURNPIKE

(Street)
BILLERICA MASSACHUSETTS 01821

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Factorial Energy Inc. [ FAC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Principal Accounting Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Series A Common Stock11/13/2026M15,000(1)A$015,000D
Series A Common Stock11/13/2026M20,495A$0.8935,495D
Series A Common Stock11/13/2026M7,011A$0.8942,506D
Series A Common Stock11/13/2026M2,494A$0.8945,000D
Series A Common Stock11/13/2026S30,000D$3.93(2)15,000D
Series A Common Stock11/16/2026S6,647(3)D$3.77(4)8,353D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units(5)11/12/2026A15,000 (6) (6)Series A Common Stock15,000$015,000D
Restricted Stock Units(5)11/13/2026M15,000 (6) (6)Series A Common Stock15,000$00D
Stock Option (Right to Buy)$0.89(7)11/13/2026M20,495 (8)03/12/2035Series A Common Stock20,495$00D
Stock Option (Right to Buy)$0.89(7)11/13/2026M7,011 (9)06/05/2034Series A Common Stock7,011$011,331D
Stock Option (Right to Buy)$0.89(7)11/13/2026M2,494 (10)05/09/2034Series A Common Stock2,494$070,874D
Explanation of Responses:
1. Represents shares of Series A Common Stock issued on settlement of RSUs that vested on November 13, 2026.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.90 to $3.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. Represents shares sold to cover tax withholding obligations arising from the vesting and settlement of RSUs. The Issuer requires these "sell-to-cover" sales; they are not discretionary trades by the Reporting Person.
4. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.71 to $3.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Series A Common Stock.
6. The RSUs were granted under the Issuer's 2026 Equity Incentive Plan in lieu of a cash payment of the Reporting Person's 2025 annual bonus and vested in full on November 13, 2026.
7. Previously reported as $0.88 due to rounding.
8. The shares underlying this option are fully vested and exercisable.
9. 25% of the shares underlying this option vested on May 8, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
10. 25% of the shares underlying this option vested on March 25, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.
Remarks:
/s/ Richard Wei, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading